Company Filing History:
1 out of 2 
1 out of 11 
1 out of 832,761 Years Active: 2011-2014
Title: Kyu-Lee Han: Innovator in Lignan Compound Therapeutics
Introduction
Kyu-Lee Han is a prominent inventor based in Seoul, South Korea, known for his significant contributions in the field of medicinal chemistry. With a total of two patents to his name, he has focused on the therapeutic applications of lignan compounds, specifically in treating inflammatory diseases and conditions mediated by PPAR (peroxisome proliferator-activated receptor).
Latest Patents
Kyu-Lee Han's latest innovations include:
1. **Use of Lignan Compounds for Treating or Preventing Inflammatory Disease**: This invention involves the administration of macelignan, a lignan compound, to inhibit inflammation by targeting mediators such as NO, iNOS, PGE, COX-2, and TNF-α. Han's research emphasizes the compound's potential to treat or prevent inflammatory diseases effectively.
2. **Method for Treating Conditions Mediated by PPAR Using Macelignan**: This patent discloses a method for treating diseases like diabetes mellitus through the administration of an effective amount of macelignan. The innovative approach highlights the compound's role in addressing PPAR-mediated conditions.
Career Highlights
Throughout his career, Kyu-Lee Han has collaborated with various organizations, contributing his expertise to the development of novel therapeutic applications. One of the notable companies he has worked with is Newtree Industry Co., Ltd., where he has significantly influenced research initiatives in biotechnology.
Collaborations
Kyu-Lee Han's work has been enhanced through collaboration with esteemed colleagues, including Jae-Kwan Hwang and Do-Un Kim. These collaborations have fostered a dynamic research environment, promoting innovation and advancing their shared goals in medicinal chemistry.
Conclusion
Kyu-Lee Han is a talented inventor whose work with lignan compounds exemplifies the forefront of medical research aimed at treating inflammatory diseases and metabolic conditions. His patented innovations reflect a commitment to improving health outcomes and demonstrate his valuable contributions to the field of medicinal research. With his ongoing dedication, Han is poised to make further advancements in therapeutic applications in the future.